LT3655395T - N-((1r,2s,sr)-5-(tret-butilamino)-2-((s)-3-(7-tret-butilpirazolo[1,5-a][1,3,5]triazin-4-ilamino)-2-oksopirolidin-1-il)cikloheksil)acetamido gamybos būdas - Google Patents
N-((1r,2s,sr)-5-(tret-butilamino)-2-((s)-3-(7-tret-butilpirazolo[1,5-a][1,3,5]triazin-4-ilamino)-2-oksopirolidin-1-il)cikloheksil)acetamido gamybos būdasInfo
- Publication number
- LT3655395T LT3655395T LTEPPCT/US2018/042797T LT18042797T LT3655395T LT 3655395 T LT3655395 T LT 3655395T LT 18042797 T LT18042797 T LT 18042797T LT 3655395 T LT3655395 T LT 3655395T
- Authority
- LT
- Lithuania
- Prior art keywords
- tret
- oxopirolidin
- butylpyrazolo
- ilamino
- butylamino
- Prior art date
Links
- DKLQJNUJPSHYQG-UHFFFAOYSA-N 2-cyclohexylacetamide Chemical compound NC(=O)CC1CCCCC1 DKLQJNUJPSHYQG-UHFFFAOYSA-N 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C269/00—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C269/06—Preparation of derivatives of carbamic acid, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups by reactions not involving the formation of carbamate groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C327/00—Thiocarboxylic acids
- C07C327/20—Esters of monothiocarboxylic acids
- C07C327/22—Esters of monothiocarboxylic acids having carbon atoms of esterified thiocarboxyl groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762534908P | 2017-07-20 | 2017-07-20 | |
| PCT/US2018/042797 WO2019018592A2 (en) | 2017-07-20 | 2018-07-19 | PROCESS FOR THE PREPARATION OF N- ((1R, 2S, 5R) -5- (TERT-BUTYLAMINO) -2 - ((S) -3- (7-TERT-BUTYLPYRAZOLO [1,5-A]] 1,3 , 5] triazin-4-ylamino) -2-oxopyrrolidin-1-yl) cyclohexyl) acetamide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LT3655395T true LT3655395T (lt) | 2022-03-10 |
Family
ID=63834628
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LTEPPCT/US2018/042797T LT3655395T (lt) | 2017-07-20 | 2018-07-19 | N-((1r,2s,sr)-5-(tret-butilamino)-2-((s)-3-(7-tret-butilpirazolo[1,5-a][1,3,5]triazin-4-ilamino)-2-oksopirolidin-1-il)cikloheksil)acetamido gamybos būdas |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US11254679B2 (lt) |
| EP (1) | EP3655395B1 (lt) |
| JP (1) | JP2020527576A (lt) |
| KR (1) | KR20200031656A (lt) |
| CN (1) | CN110933946A (lt) |
| AU (1) | AU2018304290B2 (lt) |
| BR (1) | BR112020000418A2 (lt) |
| CA (1) | CA3070423A1 (lt) |
| CY (1) | CY1125023T1 (lt) |
| DK (1) | DK3655395T3 (lt) |
| EA (1) | EA202090346A1 (lt) |
| ES (1) | ES2907640T3 (lt) |
| HR (1) | HRP20220264T8 (lt) |
| HU (1) | HUE058049T2 (lt) |
| IL (2) | IL293088A (lt) |
| LT (1) | LT3655395T (lt) |
| PL (1) | PL3655395T3 (lt) |
| PT (1) | PT3655395T (lt) |
| RS (1) | RS62941B1 (lt) |
| SG (1) | SG11202000441QA (lt) |
| SI (1) | SI3655395T1 (lt) |
| SM (1) | SMT202200088T1 (lt) |
| WO (1) | WO2019018592A2 (lt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2021511344A (ja) * | 2018-01-22 | 2021-05-06 | ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company | 癌を治療する組成物および方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2323172T3 (es) * | 2003-05-30 | 2009-07-08 | Choongwae Pharma Corporation | Mimeticos de cadena-beta. |
| US7629351B2 (en) * | 2006-07-28 | 2009-12-08 | Bristol-Myers Squibb Company | N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-2-oxo-3-(6-(trifluoromethyl)quinazolin-4-ylamino) pyrrolidin-1-yl)cyclohexyl)acetamide and other modulators of chemokine receptor activity, crystalline forms and process |
| US7671062B2 (en) * | 2006-07-28 | 2010-03-02 | Bristol-Myers Squibb Company | Modulators of chemokine receptor activity, crystalline forms and process |
| CN100593536C (zh) * | 2007-01-09 | 2010-03-10 | 吉尔生化(上海)有限公司 | 一种n-芴甲氧羰基-n-三苯甲基-d-谷氨酰胺的合成法 |
| US8383812B2 (en) | 2009-10-13 | 2013-02-26 | Bristol-Myers Squibb Company | N-((1R,2S,5R)-5-(tert-butylamino)-2-((S)-3-(7-tert-butylpyrazolo[1,5-A][1,3,5]triazin-4-ylamino)-2-oxopyrrolidin-1-yl)cyclohexyl)acetamide, a dual modulator of chemokine receptor activity, crystalline forms and processes |
| TWI787670B (zh) * | 2011-12-28 | 2022-12-21 | 日商中外製藥股份有限公司 | 具有環狀部之胜肽化合物及其醫藥組成物 |
-
2018
- 2018-07-19 SM SM20220088T patent/SMT202200088T1/it unknown
- 2018-07-19 DK DK18785785.9T patent/DK3655395T3/da active
- 2018-07-19 JP JP2020502357A patent/JP2020527576A/ja active Pending
- 2018-07-19 US US16/631,915 patent/US11254679B2/en active Active
- 2018-07-19 IL IL293088A patent/IL293088A/en unknown
- 2018-07-19 CA CA3070423A patent/CA3070423A1/en active Pending
- 2018-07-19 HR HRP20220264TT patent/HRP20220264T8/hr unknown
- 2018-07-19 EP EP18785785.9A patent/EP3655395B1/en active Active
- 2018-07-19 LT LTEPPCT/US2018/042797T patent/LT3655395T/lt unknown
- 2018-07-19 HU HUE18785785A patent/HUE058049T2/hu unknown
- 2018-07-19 RS RS20220175A patent/RS62941B1/sr unknown
- 2018-07-19 KR KR1020207004510A patent/KR20200031656A/ko active Pending
- 2018-07-19 SG SG11202000441QA patent/SG11202000441QA/en unknown
- 2018-07-19 PL PL18785785T patent/PL3655395T3/pl unknown
- 2018-07-19 WO PCT/US2018/042797 patent/WO2019018592A2/en not_active Ceased
- 2018-07-19 CN CN201880046394.0A patent/CN110933946A/zh active Pending
- 2018-07-19 BR BR112020000418-9A patent/BR112020000418A2/pt not_active IP Right Cessation
- 2018-07-19 ES ES18785785T patent/ES2907640T3/es active Active
- 2018-07-19 PT PT187857859T patent/PT3655395T/pt unknown
- 2018-07-19 SI SI201830566T patent/SI3655395T1/sl unknown
- 2018-07-19 EA EA202090346A patent/EA202090346A1/ru unknown
- 2018-07-19 AU AU2018304290A patent/AU2018304290B2/en not_active Ceased
-
2020
- 2020-01-14 IL IL272034A patent/IL272034B/en unknown
-
2022
- 2022-02-22 US US17/677,312 patent/US20220177482A1/en not_active Abandoned
- 2022-02-23 CY CY20221100161T patent/CY1125023T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20200223852A1 (en) | 2020-07-16 |
| PL3655395T3 (pl) | 2022-03-07 |
| US11254679B2 (en) | 2022-02-22 |
| AU2018304290A8 (en) | 2020-04-02 |
| SG11202000441QA (en) | 2020-02-27 |
| AU2018304290A1 (en) | 2020-03-05 |
| PT3655395T (pt) | 2022-02-22 |
| IL272034A (en) | 2020-03-31 |
| ES2907640T3 (es) | 2022-04-25 |
| WO2019018592A3 (en) | 2019-02-28 |
| US20220177482A1 (en) | 2022-06-09 |
| SMT202200088T1 (it) | 2022-03-21 |
| HRP20220264T1 (hr) | 2022-05-13 |
| IL272034B (en) | 2022-06-01 |
| KR20200031656A (ko) | 2020-03-24 |
| BR112020000418A2 (pt) | 2020-07-14 |
| RS62941B1 (sr) | 2022-03-31 |
| CY1125023T1 (el) | 2023-03-24 |
| WO2019018592A2 (en) | 2019-01-24 |
| HRP20220264T8 (hr) | 2022-05-27 |
| CN110933946A (zh) | 2020-03-27 |
| EA202090346A1 (ru) | 2020-08-18 |
| HUE058049T2 (hu) | 2022-06-28 |
| IL293088A (en) | 2022-07-01 |
| AU2018304290B2 (en) | 2022-11-17 |
| JP2020527576A (ja) | 2020-09-10 |
| SI3655395T1 (sl) | 2022-04-29 |
| EP3655395A2 (en) | 2020-05-27 |
| CA3070423A1 (en) | 2019-01-24 |
| DK3655395T3 (da) | 2022-03-07 |
| EP3655395B1 (en) | 2021-12-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUE063877T2 (hu) | (S)-N-(5-((R)-2-(2,5-dlfluorofenil)pirolidin-1-il)plrazolo[1,5-A]pirimidin-3-il) -3-hidroxipirolidin-1-karboxamid elõállítása | |
| HUE050369T2 (hu) | N - ((1,2,3,5,6,7-hexahidro-S-indacen-4-il) -karbamoil)-1-izopropil-1H-pirazol-3-szulfonamid nátrium-sója | |
| LT3317281T (lt) | (s)-4-(8-amino-3-(1-(but-2-inoil)pirolidin-2-il)imidazo[1,5-a]pirazin-1-il)-n-(piridin-2-il)benzamido kompozicijų kietosios formos | |
| LT3755703T (lt) | N-(fenil)-2-(fenil)pirimidin-4-karboksamido dariniai ir susiję junginiai, kaip hpk1 inhibitoriai, skirti vėžio gydymui | |
| DK3439662T3 (da) | Væskeformige formuleringer af (s)-n-(5-((r)-2-(2,5-difluorphenyl)-pyrrolidin-1-yl)-pyrazol[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidin-1-carboxamid | |
| WO2018042343A3 (en) | Compounds that inhibit 3c and 3cl proteases and methods of use thereof | |
| LT3494115T (lt) | N-(fenilsulfonil)benzamido dariniai kaip bcl-2 inhibitoriai | |
| HUE061448T2 (hu) | (S)-N-(5-((R)-2-(2,5-difluorofenil)-pirrolidin-1-il)-pirazolo[1,5-A]pirimidin-3-il) -3-hidroxipirrolidin-1-karboxamid-hidrogénszulfát kristályos formája | |
| IL253700A0 (en) | Pharmaceutical preparations containing n-(3,5-dimethoxyphenyl)-n'-(1-methylethyl)-n-[3-(1-methyl-1h-pyrazol-4-yl)quinoxalin-6-yl]ethane-1, 2-diamine | |
| IL279810A (en) | Heteroaryl-converted sulfonamide compounds and their use as medicinal agents | |
| EP3856174A4 (en) | HDAC1, 2 INHIBITORS | |
| DK3259255T3 (da) | (2r,4r)-5-(5'-chlor-2'-fluorbiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazol-2-carbonyl)amino]pentansyre | |
| LT3655395T (lt) | N-((1r,2s,sr)-5-(tret-butilamino)-2-((s)-3-(7-tret-butilpirazolo[1,5-a][1,3,5]triazin-4-ilamino)-2-oksopirolidin-1-il)cikloheksil)acetamido gamybos būdas | |
| EA201792558A1 (ru) | Противогрибковый 4-(4-(4-(((3r,5r)-5-((1h-1,2,4-триазол-1-ил)метил)-5-(2,4-дифторфенил)тетрагидрофуран-3-ил)метокси)-3-метилфенил)пиперазин-1-ил)-n-(2-гидроксициклогексил)бензамид или его фармацевтически приемлемая соль | |
| HUE046959T2 (hu) | Eljárás N-(3,5-dimetilfenil)-N'-(2-trifluormetilfenil) guanidin elõállítására | |
| EP3593798A4 (en) | MEDICAL USES OF N- (2-AMINOETHYL) -N- (4-BENZYLOXY) -3-METHOXYBENZYL) THIOPHENE-2-FORMAMIDE | |
| HK1242618A1 (en) | Pharmaceutical compositions comprising n-(3,5-dimethoxyphenyl)-n'-(1-methylethyl)-n-[3-(1-methyl-1h-pyrazol-4-yl)quinoxalin-6-yl]ethane-1,2-diamine | |
| RU2016111950A (ru) | Использование 3,4,5-триметокси-N'(2,2,6,6-тетраметил-пиперидин-4-илиден)бензогидразида гидрохлорида в качестве анксиолитического средства | |
| UA98069U (xx) | N-(3-ТРИФТОРМЕТИЛФЕНІЛ)-2-(2-ОКСО-3,5a,6,11b-ТЕТРАГІДРО-2Н,5Н-ХРОМЕНО[4',3':4,5]ТІОПІРАНО[2,3-d][1,3]ТІАЗОЛ-3-ІЛ)АЦЕТАМІД, ЩО ПРОЯВЛЯЄ АНАБОЛІЧНУ ТА АНДРОГЕННУ ДІЮ |